Lack of association between apolipoprotein E genotypes and cognitive performance in the non-demented elderly

Psychogeriatrics

Volumn 14, Issue 1, 2014, Pages 11-16

  Quintas, Juliana Lima ^a   Souza, Vinícius Carolino ^a   Henriques, Adriane Dallanora ^a   Machado Silva, Wilcelly ^a   Toledo, Juliana Oliveira ^a   Córdova, Cláudio ^b   Moraes, Clayton Franco ^a,b   Camargos, Einstein Francisco ^a   Nóbrega, Otávio Toledo ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

Age associated memory problems; Apolipoprotein; Cognitive functioning; Genetics; Neuropsychology

Indexed keywords

APOLIPOPROTEIN E;

AGED; ARTICLE; ATTENTION; COGNITION; CROSS-SECTIONAL STUDY; DEPRESSION; EDUCATIONAL STATUS; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RESPONSE TIME; SHORT TERM MEMORY; BRAZIL; GENETICS; GERIATRIC ASSESSMENT; PHYSIOLOGY; PROCEDURES; REACTION TIME; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; APOLIPOPROTEINS E; ATTENTION; BRAZIL; COGNITION; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; MALE; MEMORY, EPISODIC; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; RISK FACTORS;

EID: 84896393194     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12029     Document Type: Article

References (31)

1. Ferri CP, Prince M, Brayne C etal. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-2117.
2. APA. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
3. Bertram L, Lange C, Mullin K etal. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 2008; 83: 623-632.
4. Bookheimer S, Burggren A. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu Rev Clin Psychol 2009; 5: 343-362.
5. Yip AG, McKee AC, Green RC etal. APOE, vascular pathology, and the AD brain. Neurology 2005; 65: 259-265.
6. Moraes CF, Lins TC, Carmargos EF, Naves JOS, Pereira RW, Nóbrega OT. Lessons from genome-wide association studies findings in Alzheimer's disease. Psychogeriatrics 2012; 12: 62-73.
7. Tuminello ER, Han SD. The apolipoprotein E antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimers Dis 2011; doi: 10.4061/2011/726197.
8. Caselli RJ, Reiman EM, Locke DE etal. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol 2007; 64: 1306-1311.
9. Bunce D, Anstey KJ, Burns R, Christensen H, Easteal S. Does possession of apolipoprotein E varepsilon4 benefit cognitive function in healthy young adults? Neuropsychologia 2011; 49: 1693-1697.
10. Castro-Costa E, Fuzikawa C, Uchoa E, Firmo JO, Lima-Costa MF. Norms for the Mini-Mental State Examination: adjustment of the cut-off point in population-based studies (evidences from the Bambui health aging study). Arq Neuropsiquiatr 2008; 66: 524-528.
11. Donohoe GG, Salomaki A, Lehtimaki T, Pulkki K, Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem 1999; 45: 143-146.
12. Paula RS, Souza VC, Benedet AL etal. Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women. Mol Cell Biochem 2010; 337: 307-315.
13. Yesavage JA, Brink TL, Rose TL etal. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17: 37-49.
14. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Wechsler D. WMS-III Wechsler Memory Scale, 3rd edn. San Antonio, TX: Psychological Corporation, 1997; Manual.
16. Wechsler D. WAIS-III Wechsler Adult Intelligence Scale, 3rd edn. San Antonio, TX: Psychological Corporation, 1997; Manual.
17. Córdova C, Bravin AA, Barros JF. TEVA: programa computadorizado para registro e processamento da atenção visual em investigações com retardados mentais leves. Lecturas Educación Física Y Deportes 2005; 10: 5 (in Brazilian Portuguese).
18. Sullivan JR, Riccio CA, Castillo CL. Concurrent validity of the tower tasks as measures of executive function in adults: a meta-analysis. Appl Neuropsychol 2009; 16: 62-75.
19. Ahonniska J, Ahonen T, Aro T, Tolvanen A, Lyytinen H. Repeated assessment of the Tower of Hanoi test: reliability and age effects. Assessment 2000; 7: 297-310.
20. Corder EH, Lannfelt L, Bogdanovic N, Fratiglioni L, Mori H. The role of APOE polymorphisms in late-onset dementias. Cell Mol Life Sci 1998; 54: 928-934.
21. Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 641-650.
22. Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 2004; 23: 189-204.
23. Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003; 84: 1215-1236.
24. Greenwood PM, Parasuraman R. Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev 2003; 2: 278-306.
25. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005; 76: 1479-1484.
26. Kluger A, Ferris SH, Golomb J, Mittelman MS, Reisberg B. Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol 1999; 12: 168-179.
27. Vos SJ, van Rossum IA, Verhey F etal. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology 2013; 80: 1124-1132.
28. Heun R, Guhne U, Luck T etal. Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment. Eur Psychiatry 2010; 25: 15-18.
29. Alexander DM, Williams LM, Gatt JM etal. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol 2007; 75: 229-238.
30. Jorm AF, Mather KA, Butterworth P, Anstey KJ, Christensen H, Easteal S. APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 2007; 21: 1-8.
31. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edn. Oxford and New York: Oxford University Press, 2006.